Back
LENSAR 10K Form
Sell
34
LNSR
LENSAR
Last Price:
4.31
Seasonality Move:
-28.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-12 | 10K | LNSR/LENSAR Annual |
| 2020-11-12 | 10Q | LNSR/LENSAR Quarterly |
Receive LNSR News And Ratings
See the #1 stock for the next 7 days that we like better than LNSR
LNSR Financial Statistics
Sales & Book Value
| Annual Sales: | $42.16M |
|---|---|
| Cash Flow: | $-3.89M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.05 |
| Price / Book: | 2.06 |
Profitability
| EPS (TTM): | -1.56000 |
|---|---|
| Net Income (TTM): | $-12.56M |
| Gross Margin: | $21.11M |
| Return on Equity: | -39.75% |
| Return on Assets: | -18.51% |
LENSAR Earnings Forecast
Key LENSAR Financial Ratios
- The Gross Profit Margin over the past 5 years for LNSR is 50.06%.
- The Selling, General & Administrative Expenses for LNSR have been equal to 61.90% of Gross Profit Margin.
- The Research & Development expenses have been 14.56% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of LNSR is -34.11% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
LENSAR Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LNSR |
| Website: | lensar.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.88 |
| Quick Ratio: | 1.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |